Roberto Gambari
10Patents
2h-index
31Co-inventors
50Inventor score
Filing activity: Mar 13, 2001 → Jul 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9321730B2 | Method of making and administering quinoline derivatives as anti-cancer agents | Human Necessities | 9 | Active |
| US7541380B2 | Use of rapamycin and structural analogues thereof | Human Necessities | 4 | Expired |
| US7572827B2 | Use of angelicin and of its structural analogues for the treatment of thalassemia | Human Necessities | 2 | Expired |
| US7262175B2 | Synthetic oligonucleotides as inducers of erythroid differentiation | Human Necessities | 1 | Expired |
| US11077116B2 | Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients | Human Necessities | 0 | Active |
| US7396851B2 | Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia | Human Necessities | 0 | Expired |
| US9371295B2 | Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC | Chemistry; Metallurgy | 0 | Active |
| US9283206B2 | Trimethylangelicin as CFTR corrector in bronchial epithelial cells | Human Necessities | 0 | Active |
| US7659258B2 | Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies | Chemistry; Metallurgy | 0 | Active |
| US9528981B2 | Diagnostic and therapeutic application of CTL and NK functionally selected cells | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.